Fred Alger Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,373
| Closed | -$860K | – | 438 |
|
|
2025
Q1 | $860K | Buy |
+7,373
| New | +$860K | ﹤0.01% | 334 |
|
|
2024
Q4 | – | Sell |
-9,466
| Closed | -$851K | – | 416 |
|
|
2024
Q3 | $851K | Buy |
+9,466
| New | +$851K | ﹤0.01% | 354 |
|
|
2023
Q3 | – | Sell |
-17,422
| Closed | -$1.25M | – | 470 |
|
|
2023
Q2 | $1.25M | Buy |
+17,422
| New | +$1.25M | 0.01% | 368 |
|
|
2021
Q1 | – | Sell |
-14,670
| Closed | -$1.2M | – | 483 |
|
|
2020
Q4 | $1.2M | Sell |
14,670
-331
| -2% | -$27K | ﹤0.01% | 357 |
|
|
2020
Q3 | $1.07M | Sell |
15,001
-7,999
| -35% | -$570K | ﹤0.01% | 339 |
|
|
2020
Q2 | $1.89M | Buy |
23,000
+4,000
| +21% | +$329K | 0.01% | 306 |
|
|
2020
Q1 | $1.12M | Buy |
19,000
+3,000
| +19% | +$177K | ﹤0.01% | 309 |
|
|
2019
Q4 | $1.65M | Buy |
16,000
+1,000
| +7% | +$103K | 0.01% | 304 |
|
|
2019
Q3 | $304K | Sell |
15,000
-5,000
| -25% | -$101K | ﹤0.01% | 390 |
|
|
2019
Q2 | $515K | Buy |
+20,000
| New | +$515K | ﹤0.01% | 379 |
|